MedCity News is Accepting Applications for the Healthcare Startup Pitch Perfect Contest in Chicago

2024-01-10

Are you a healthcare startup in health tech, diagnostics, medtech, or biotech? If so, you should consider applying to the MedCity News startup pitch contest at the INVEST conference at the Ritz Carlton in Chicago, May 21-22. The Pitch Perfect contest has four tracks geared to a specialty in each category: Biopharma Startups focused on oncology. Devices & Diagnostics Startups focused on cardiology. Healthtech: Consumer/Employer Startups addressing women’s health. Healthtech: Payer/Provider Startups addressing burnout and operational efficiency. Six finalists will be selected for each track. The finalists have the opportunity to present to an audience of investors. The investor judges in each track will hear each pitch and ask questions of each presenter before selecting a winner. There is no fee to apply. Startups that have been a finalist and pitched at any INVEST event in the past 12 months are not eligible to apply. Startups should apply to only one track. Startups must be registered for the conference in order to participate in the pitch contest. The startup rate is $695 and a code will be sent to you if you are selected to pitch. Application Deadline: February 29, 2024. Investment professionals are reviewing applications and selections will be announced starting March 31, 2024. Disclaimer: Each Pitch Track winner will receive a $20,000 advertising credit to be used on MedCityNews.com. The advertising opportunities that are available to select from include: display advertising, sponsored post, sponsored text ad, dedicated and targeted email blast, executive interview, and video spotlight. A MedCity News media kit will be provided to each winner to reference the rate for each opportunity included above. Advertising credit must be used by May 21, 2024, cannot exceed $20,000 in value, and may not be combined with any other offers or discounts. To submit an application, click here.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构